Proud, C.2014-06-182014-06-182009Journal of Molecular Cell Biology, 2009; 1(2):61-631674-27881759-4685http://hdl.handle.net/2440/83509The mammalian target of rapamycin, mTOR, is a key node in cellular regulation: its dysregulation is important in a number of disease states, including various cancers. A recent study identifies a new partner and regulator of mTOR, which can alter the balance of signaling downstream of mTOR and appears to be important in certain cancers, such as multiple myelomas.en© The Author (2009).AnimalsHumansMultiple MyelomaIntracellular Signaling Peptides and ProteinsCarrier ProteinsSignal TransductionEnzyme ActivationProtein BindingModels, BiologicalProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesProtein Serine-Threonine KinasesJournal article002012804310.1093/jmcb/mjp0120002078131000032-s2.0-7744909090119764Proud, C. [0000-0003-0704-6442]